PDF herunterladen
Semin Neurol 2014; 34(01): 103-116
DOI: 10.1055/s-0034-1372347
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

HIV-Associated Central Nervous System Tuberculosis

Gabriel Chamie
1   HIV/AIDS Division, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, California
,
Carina Marquez
1   HIV/AIDS Division, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, California
,
Anne Luetkemeyer
1   HIV/AIDS Division, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, California
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
08. April 2014 (online)

    Lizenzen und Reprints

Abstract

Central nervous system tuberculosis (CNS TB) represents one of the most devastating manifestations of TB. HIV dramatically increases the risk of TB disease, including CNS TB. Early recognition and treatment of CNS TB, and TB meningitis in particular, is of critical importance to reducing disability and death associated with CNS TB. The diagnosis and treatment of HIV-associated CNS TB presents particular challenges for clinicians due to the increased risk of other CNS infections and malignancies, atypical cerebrospinal fluid characteristics, drug-drug interactions, timing of antiretroviral therapy and immune reconstitution inflammatory syndrome, and the increased risk of poor clinical outcomes in HIV-infected compared with HIV-uninfected CNS TB patients. The authors review recent updates and highlight challenges specific to CNS TB in the HIV-infected patient.

Keywords

human immunodeficiency virus - central nervous system - tuberculosis - tuberculosis meningitis
 

  • References

  • 1 Berenguer J, Moreno S, Laguna F , et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992; 326 (10) 668-672
    CrossrefPubMedGoogle Scholar
  • 2 Ansari NA, Kombe AH, Kenyon TA , et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis 2002; 6 (1) 55-63
    PubMedGoogle Scholar
  • 3 Rana FS, Hawken MP, Mwachari C , et al. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 2000; 24 (1) 23-29
    CrossrefPubMedGoogle Scholar
  • 4 Thwaites GE, Nguyen DB, Nguyen HD , et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351 (17) 1741-1751
    CrossrefPubMedGoogle Scholar
  • 5 Geldmacher C, Zumla A, Hoelscher M. Interaction between HIV and Mycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis. Curr Opin HIV AIDS 2012; 7 (3) 268-275
    PubMedGoogle Scholar
  • 6 Kalsdorf B, Scriba TJ, Wood K , et al. HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am J Respir Crit Care Med 2009; 180 (12) 1262-1270
    CrossrefPubMedGoogle Scholar
  • 7 Donald PR, Schaaf HS, Schoeman JF. Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J Infect 2005; 50 (3) 193-195
    CrossrefPubMedGoogle Scholar
  • 8 Phypers M, Harris T, Power C. CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features. Int J Tuberc Lung Dis 2006; 10 (1) 99-103
    PubMedGoogle Scholar
  • 9 Yechoor VK, Shandera WX, Rodriguez P, Cate TR. Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital. Arch Intern Med 1996; 156 (15) 1710-1716
    CrossrefPubMedGoogle Scholar
  • 10 Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis 2010; 50 (3) (Suppl. 03) S184-S194
    CrossrefPubMedGoogle Scholar
  • 11 Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med 2012; 367 (4) 348-361
    CrossrefPubMedGoogle Scholar
  • 12 Topley JM, Bamber S, Coovadia HM, Corr PD. Tuberculous meningitis and co-infection with HIV. Ann Trop Paediatr 1998; 18 (4) 261-266
    PubMedGoogle Scholar
  • 13 Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Enarson DA, Beyers N. The spectrum of disease in children treated for tuberculosis in a highly endemic area. Int J Tuberc Lung Dis 2006; 10 (7) 732-738
    PubMedGoogle Scholar
  • 14 Dubé MP, Holtom PD, Larsen RA. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med 1992; 93 (5) 520-524
    CrossrefPubMedGoogle Scholar
  • 15 Thwaites GE, Duc Bang N, Huy Dung N , et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis 2005; 192 (12) 2134-2141
    CrossrefPubMedGoogle Scholar
  • 16 Ho J, Marais BJ, Gilbert GL, Ralph AP. Diagnosing tuberculous meningitis - have we made any progress?. Trop Med Int Health 2013; 18 (6) 783-793
    CrossrefPubMedGoogle Scholar
  • 17 Bhagwan S, Naidoo K. Aetiology, clinical presentation, and outcome of meningitis in patients coinfected with human immunodeficiency virus and tuberculosis. AIDS Res Treat 2011; 2011; 180352
    PubMedGoogle Scholar
  • 18 Hosoglu S, Geyik MF, Balik I , et al. Predictors of outcome in patients with tuberculous meningitis. Int J Tuberc Lung Dis 2002; 6 (1) 64-70
    PubMedGoogle Scholar
  • 19 Perfect JR, Dismukes WE, Dromer F , et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010; 50 (3) 291-322
    CrossrefPubMedGoogle Scholar
  • 20 Jarvis JN, Percival A, Bauman S , et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis 2011; 53 (10) 1019-1023
    CrossrefPubMedGoogle Scholar
  • 21 Whiteman M, Espinoza L, Post MJ, Bell MD, Falcone S. Central nervous system tuberculosis in HIV-infected patients: clinical and radiographic findings. AJNR Am J Neuroradiol 1995; 16 (6) 1319-1327
    PubMedGoogle Scholar
  • 22 Gallant JE, Mueller PS, McArthur JC, Chaisson RE. Intramedullary tuberculoma in a patient with HIV infection. AIDS 1992; 6 (8) 889-891
    CrossrefPubMedGoogle Scholar
  • 23 Martínez-Vázquez C, Bordón J, Rodríguez-González A , et al. Cerebral tuberculoma—a comparative study in patients with and without HIV infection. Infection 1995; 23 (3) 149-153
    CrossrefPubMedGoogle Scholar
  • 24 Woolsey RM, Chambers TJ, Chung HD, McGarry JD. Mycobacterial meningomyelitis associated with human immunodeficiency virus infection. Arch Neurol 1988; 45 (6) 691-693
    CrossrefPubMedGoogle Scholar
  • 25 Vidal JE, Cimerman S, da Silva PR, Sztajnbok J, Coelho JF, Lins DL. Tuberculous brain abscess in a patient with AIDS: case report and literature review. Rev Inst Med Trop Sao Paulo 2003; 45 (2) 111-114
    CrossrefPubMedGoogle Scholar
  • 26 Corti ME, Villafañe MF, Yampolsky CG, Schtirbu RB. Brain abscess due to Mycobacterium tuberculosis in a patient with AIDS: report of a case and review of the literature. Int J Infect Dis 2005; 9 (4) 225-227
    CrossrefPubMedGoogle Scholar
  • 27 Vidal JE, Oliveira AC, Dauar RF. Cerebral tuberculomas or tuberculous brain abscess: the dilemma continues. Clin Infect Dis 2005; 40 (7) 1072-1073 , author reply 1072–1073
    PubMedGoogle Scholar
  • 28 Farrar DJ, Flanigan TP, Gordon NM, Gold RL, Rich JD. Tuberculous brain abscess in a patient with HIV infection: case report and review. Am J Med 1997; 102 (3) 297-301
    CrossrefPubMedGoogle Scholar
  • 29 Vidal JE, Penalva de Oliveira AC, Bonasser Filho F , et al. Tuberculous brain abscess in AIDS patients: report of three cases and literature review. Int J Infect Dis 2005; 9 (4) 201-207
    CrossrefPubMedGoogle Scholar
  • 30 Thwaites GE, Chau TT, Stepniewska K , et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002; 360 (9342) 1287-1292
    CrossrefPubMedGoogle Scholar
  • 31 Checkley AM, Njalale Y, Scarborough M, Zjilstra EE. Sensitivity and specificity of an index for the diagnosis of TB meningitis in patients in an urban teaching hospital in Malawi. Trop Med Int Health 2008; 13 (8) 1042-1046
    CrossrefPubMedGoogle Scholar
  • 32 Cecchini D, Ambrosioni J, Brezzo C , et al. Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings. Int J Tuberc Lung Dis 2009; 13 (2) 269-271
    PubMedGoogle Scholar
  • 33 Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD. The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci 2000; 181 (1-2) 118-126
    CrossrefPubMedGoogle Scholar
  • 34 Vidal JE, de Oliveira AC, Hernández AV. CD4+ T-cell count and cerebrospinal fluid findings in HIV-infected patients with tuberculous meningitis. Int J Tuberc Lung Dis 2010; 14 (11) 1496-1497 , author reply 1497
    PubMedGoogle Scholar
  • 35 Laguna F, Adrados M, Ortega A, Gonzalez-Lahoz JM. Tuberculous meningitis with acellular cerebrospinal fluid in AIDS patients. AIDS 1992; 6 (10) 1165-1167
    CrossrefPubMedGoogle Scholar
  • 36 Chen P, Shi M, Feng GD , et al. A highly efficient Ziehl-Neelsen stain: identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid. J Clin Microbiol 2012; 50 (4) 1166-1170
    CrossrefPubMedGoogle Scholar
  • 37 Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculous meningitis. J Clin Microbiol 2004; 42 (1) 378-379
    CrossrefPubMedGoogle Scholar
  • 38 Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford Jr JM. Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2003; 3 (10) 633-643
    CrossrefPubMedGoogle Scholar
  • 39 World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva, Switzerland: World Health Organization; 2010
    Google Scholar
  • 40 Horne DJ, Royce SE, Gooze L , et al. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis 2010; 10 (6) 387-394
    CrossrefPubMedGoogle Scholar
  • 41 Boehme CC, Nabeta P, Hillemann D , et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363 (11) 1005-1015
    CrossrefPubMedGoogle Scholar
  • 42 Tortoli E, Russo C, Piersimoni C , et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012; 40 (2) 442-447
    CrossrefPubMedGoogle Scholar
  • 43 Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?. J Clin Microbiol 2011; 49 (7) 2540-2545
    CrossrefPubMedGoogle Scholar
  • 44 Patel VB, Theron G, Lenders L , et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med 2013; 10 (10) e1001536
    CrossrefPubMedGoogle Scholar
  • 45 Corral I, Quereda C, Navas E , et al. Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis. Eur J Clin Microbiol Infect Dis 2004; 23 (6) 471-476
    CrossrefPubMedGoogle Scholar
  • 46 Tuon FF, Higashino HR, Lopes MI , et al. Adenosine deaminase and tuberculous meningitis—a systematic review with meta-analysis. Scand J Infect Dis 2010; 42 (3) 198-207
    CrossrefPubMedGoogle Scholar
  • 47 van der Merwe DJ, Andronikou S, Van Toorn R, Pienaar M. Brainstem ischemic lesions on MRI in children with tuberculous meningitis: with diffusion weighted confirmation. Childs Nerv Syst 2009; 25 (8) 949-954
    CrossrefPubMedGoogle Scholar
  • 48 Bernaerts A, Vanhoenacker FM, Parizel PM , et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol 2003; 13 (8) 1876-1890
    CrossrefPubMedGoogle Scholar
  • 49 Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345 (24) 1727-1733
    CrossrefPubMedGoogle Scholar
  • 50 Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008; (1) CD002244
    PubMedGoogle Scholar
  • 51 Schoeman JF, Janse van Rensburg A, Laubscher JA, Springer P. The role of aspirin in childhood tuberculous meningitis. J Child Neurol 2011; 26 (8) 956-962
    CrossrefPubMedGoogle Scholar
  • 52 Misra UK, Kalita J, Nair PP. Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci 2010; 293 (1-2) 12-17
    CrossrefPubMedGoogle Scholar
  • 53 Blumberg HM, Burman WJ, Chaisson RE , et al; American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167 (4) 603-662
    CrossrefPubMedGoogle Scholar
  • 54 Cecchini D, Ambrosioni J, Brezzo C , et al. Tuberculous meningitis in HIV-infected patients: drug susceptibility and clinical outcome. AIDS 2007; 21 (3) 373-374
    CrossrefPubMedGoogle Scholar
  • 55 Thwaites GE, Lan NT, Dung NH , et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005; 192 (1) 79-88
    CrossrefPubMedGoogle Scholar
  • 56 Alffenaar JW, van Altena R, Bökkerink HJ , et al. Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. Clin Infect Dis 2009; 49 (7) 1080-1082
    CrossrefPubMedGoogle Scholar
  • 57 Shandil RK, Jayaram R, Kaur P , et al. Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy. Antimicrob Agents Chemother 2007; 51 (2) 576-582
    CrossrefPubMedGoogle Scholar
  • 58 Donald PR, Seifart HI. Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis. J Pediatr 1989; 115 (3) 483-486
    CrossrefPubMedGoogle Scholar
  • 59 Ruslami R, Ganiem AR, Dian S , et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis 2013; 13 (1) 27-35
    CrossrefPubMedGoogle Scholar
  • 60 Alvarez-Uria G, Midde M, Pakam R, Naik PK. Initial antituberculous regimen with better drug penetration into cerebrospinal fluid reduces mortality in HIV infected patients with tuberculous meningitis: data from an HIV observational cohort study. Tuberc Res Treat 2013; , 2013 242604
    PubMedGoogle Scholar
  • 61 ISRCTN61649292. A randomised, double-blind, placebo-controlled trial to investigate the effect of intensified treatment with high dose rifampicin and levofloxacin for adult patients with tuberculous meningitis. Available at: http://www.controlled-trials.com/ISRCTN61649292 . Accessed November 26, 2013
    PubMedGoogle Scholar
  • 62 Cattamanchi A, Dantes RB, Metcalfe JZ , et al. Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis. Clin Infect Dis 2009; 48 (2) 179-185
    CrossrefPubMedGoogle Scholar
  • 63 Grinsztejn B, De Castro N, Arnold V , et al. A randomized multicentre open-label trial to estimate the efficacy and safety of two doses of raltegravir (RAL) to efavirenz (EFV) for the treatment of HIV-TB co-infected patients: results of the ANRS 12 180 Reflate TB trial. Paper presented at: 19th International AIDS Conference; June 30–July 3, 2013; Kuala Lumpur, Malaysia
    PubMedGoogle Scholar
  • 64 Dooley KE, Sayre P, Borland J , et al. Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjects. J Acquir Immune Defic Syndr 2013; 62 (1) 21-27
    CrossrefPubMedGoogle Scholar
  • 65 Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. U.S. Department of Health and Human Services. Available at: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf . Accessed September 15, 2013
    PubMedGoogle Scholar
  • 66 Abdool Karim SS, Naidoo K, Grobler A , et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011; 365 (16) 1492-1501
    CrossrefPubMedGoogle Scholar
  • 67 Blanc FX, Sok T, Laureillard D , et al; CAMELIA (ANRS 1295–CIPRA KH001) Study Team. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011; 365 (16) 1471-1481
    CrossrefPubMedGoogle Scholar
  • 68 Havlir DV, Kendall MA, Ive P , et al; AIDS Clinical Trials Group Study A5221. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011; 365 (16) 1482-1491
    CrossrefPubMedGoogle Scholar
  • 69 Török ME, Yen NT, Chau TT , et al. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)—associated tuberculous meningitis. Clin Infect Dis 2011; 52 (11) 1374-1383
    CrossrefPubMedGoogle Scholar
  • 70 Marais S, Meintjes G, Pepper DJ , et al. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis 2013; 56 (3) 450-460
    CrossrefPubMedGoogle Scholar
  • 71 El Sahly HM, Teeter LD, Pan X, Musser JM, Graviss EA. Mortality associated with central nervous system tuberculosis. J Infect 2007; 55 (6) 502-509
    CrossrefPubMedGoogle Scholar
  • 72 Tho DQ, Török ME, Yen NT , et al. Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis. Antimicrob Agents Chemother 2012; 56 (6) 3074-3079
    CrossrefPubMedGoogle Scholar
  • 73 Luma HN, Tchaleu BC, Ngahane BH , et al. Tuberculous meningitis: presentation, diagnosis and outcome in hiv-infected patients at the douala general hospital, cameroon: a cross sectional study. AIDS Res Ther 2013; 10 (1) 16
    CrossrefPubMedGoogle Scholar
  • 74 Pepper DJ, Marais S, Maartens G , et al. Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009; 48 (11) e96-e107
    CrossrefPubMedGoogle Scholar
  • 75 Middelkoop K, Bekker LG, Myer L , et al. Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med 2010; 182 (8) 1080-1085
    CrossrefPubMedGoogle Scholar
  • 76 Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol 2013; 12 (10) 999-1010
    CrossrefPubMedGoogle Scholar
  • 77 Thwaites GE, Chau TT, Stepniewska K , et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002; 360 (9342) 1287-1292
    CrossrefPubMedGoogle Scholar
  • 78 Ho J, Marais BJ, Gilbert GL, Ralph AP. Diagnosing tuberculous meningitis - have we made any progress?. Trop Med Int Health 2013; 18 (6) 783-793
    CrossrefPubMedGoogle Scholar
  • 79 Patel VB, Theron G, Lenders L , et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med 2013; 10 (10) e1001536
    CrossrefPubMedGoogle Scholar
  • 80 Darras-Joly C, Chevret S, Wolff M , et al. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin Infect Dis 1996; 23 (2) 369-376
    CrossrefPubMedGoogle Scholar
  • 81 Rozenbaum R, Gonçalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994; 18 (3) 369-380
    CrossrefPubMedGoogle Scholar
  • 82 Asawavichienjinda T, Sitthi-Amorn C, Tanyanont V. Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis. J Med Assoc Thai 1999; 82 (1) 65-71
    PubMedGoogle Scholar
  • 83 McNeil MM, Ampel NM. Opportunistic coccidioidomycosis in patients infected with human immunodeficiency virus: prevention issues and priorities. Clin Infect Dis 1995; 21 (Suppl. 01) S111-S113
    CrossrefPubMedGoogle Scholar
  • 84 Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis 2010; 50 (1) 1-7
    CrossrefPubMedGoogle Scholar
  • 85 Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis 2006; 42 (1) 103-107
    CrossrefPubMedGoogle Scholar
  • 86 Wheat LJ, Connolly-Stringfield PA, Baker RL , et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69 (6) 361-374
    CrossrefPubMedGoogle Scholar
  • 87 Hage CA, Ribes JA, Wengenack NL , et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011; 53 (5) 448-454
    CrossrefPubMedGoogle Scholar
  • 88 Pappas PG, Pottage JC, Powderly WG , et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116 (10) 847-853
    CrossrefPubMedGoogle Scholar
  • 89 Bariola JR, Perry P, Pappas PG , et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 2010; 50 (6) 797-804
    CrossrefPubMedGoogle Scholar
  • 90 Durkin M, Witt J, Lemonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004; 42 (10) 4873-4875
    CrossrefPubMedGoogle Scholar
  • 91 Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis 2007; 44 (9) 1222-1228
    CrossrefPubMedGoogle Scholar
  • 92 Marra CM, Maxwell CL, Tantalo L , et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter?. Clin Infect Dis 2004; 38 (7) 1001-1006
    CrossrefPubMedGoogle Scholar
  • 93 Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98 (6) 958-972
    CrossrefPubMedGoogle Scholar
  • 94 Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008; 28 (7) 2033-2058
    CrossrefPubMedGoogle Scholar
  • 95 Tan IL, Smith BR, von Geldern G, Mateen FJ, McArthur JC. HIV-associated opportunistic infections of the CNS. Lancet Neurol 2012; 11 (7) 605-617
    CrossrefPubMedGoogle Scholar
  • 96 Bylsma SS, Achim CL, Wiley CA , et al. The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Arch Ophthalmol 1995; 113 (1) 89-95
    CrossrefPubMedGoogle Scholar
  • 97 Guven T, Ugurlu K, Ergonul O , et al. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis 2013; 56 (10) 1407-1412
    CrossrefPubMedGoogle Scholar
  • 98 Al-Sous MW, Bohlega S, Al-Kawi MZ, Alwatban J, McLean DR. Neurobrucellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol 2004; 25 (3) 395-401
    PubMedGoogle Scholar
  • 99 Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM. Leptomeningeal metastases in the MRI era. Neurology 2010; 74 (18) 1449-1454
    CrossrefPubMedGoogle Scholar
  • 100 Bernaerts A, Vanhoenacker FM, Parizel PM , et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur Radiol 2003; 13 (8) 1876-1890
    CrossrefPubMedGoogle Scholar
  • 101 Gupta RK, Vatsal DK, Husain N , et al. Differentiation of tuberculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol 2001; 22 (8) 1503-1509
    PubMedGoogle Scholar
  • 102 Tan IL, Smith BR, von Geldern G, Mateen FJ, McArthur JC. HIV-associated opportunistic infections of the CNS. Lancet Neurol 2012; 11 (7) 605-617
    CrossrefPubMedGoogle Scholar
  • 103 Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol 2013; 12 (10) 999-1010
    CrossrefPubMedGoogle Scholar
  • 104 Smith AB, Smirniotopoulos JG, Rushing EJ. From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008; 28 (7) 2033-2058
    CrossrefPubMedGoogle Scholar
  • 105 Antinori A, Larussa D, Cingolani A , et al; Italian Registry Investigative NeuroAIDS. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis 2004; 39 (11) 1681-1691
    CrossrefPubMedGoogle Scholar
  • 106 Kupfer MC, Zee CS, Colletti PM, Boswell WD, Rhodes R. MRI evaluation of AIDS-related encephalopathy: toxoplasmosis vs. lymphoma. Magn Reson Imaging 1990; 8 (1) 51-57
    CrossrefPubMedGoogle Scholar
  • 107 Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992; 327 (23) 1643-1648
    CrossrefPubMedGoogle Scholar
  • 108 Thurnher MM, Thurnher SA, Schindler E. CNS involvement in AIDS: spectrum of CT and MR findings. Eur Radiol 1997; 7 (7) 1091-1097
    CrossrefPubMedGoogle Scholar
  • 109 Jenkins CN, Colquhoun IR. Characterization of primary intracranial lymphoma by computed tomography: an analysis of 36 cases and a review of the literature with particular reference to calcification haemorrhage and cyst formation. Clin Radiol 1998; 53 (6) 428-434
    CrossrefPubMedGoogle Scholar
  • 110 Forsyth PA, DeAngelis LM. Biology and management of AIDS-associated primary CNS lymphomas. Hematol Oncol Clin North Am 1996; 10 (5) 1125-1134
    CrossrefPubMedGoogle Scholar
  • 111 Rozenbaum R, Gonçalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994; 18 (3) 369-380
    CrossrefPubMedGoogle Scholar
  • 112 Perfect JR, Dismukes WE, Dromer F , et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010; 50 (3) 291-322
    CrossrefPubMedGoogle Scholar
  • 113 Tan K, Roda R, Ostrow L, McArthur J, Nath A. PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 2009; 72 (17) 1458-1464
    CrossrefPubMedGoogle Scholar
  • 114 Weissert R. Progressive multifocal leukoencephalopathy. J Neuroimmunol 2011; 231 (1-2) 73-77
    CrossrefPubMedGoogle Scholar
  • 115 Cordova E, Boschi A, Ambrosioni J, Cudos C, Corti M. Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007. Int J Infect Dis 2008; 12 (6) 587-592
    CrossrefPubMedGoogle Scholar
  • 116 Diazgranados CA, Saavedra-Trujillo CH, Mantilla M, Valderrama SL, Alquichire C, Franco-Paredes C. Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis 2009; 9 (5) 324-330
    CrossrefPubMedGoogle Scholar